These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 30356945)
1. A Broad-Spectrum ROS-Eliminating Material for Prevention of Inflammation and Drug-Induced Organ Toxicity. Li L; Guo J; Wang Y; Xiong X; Tao H; Li J; Jia Y; Hu H; Zhang J Adv Sci (Weinh); 2018 Oct; 5(10):1800781. PubMed ID: 30356945 [TBL] [Abstract][Full Text] [Related]
2. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity. Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351 [TBL] [Abstract][Full Text] [Related]
3. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies. Yuan J; Li L; Yang Q; Ran H; Wang J; Hu K; Pu W; Huang J; Wen L; Zhou L; Jiang Y; Xiong X; Zhang J; Zhou Z ACS Nano; 2021 Oct; 15(10):16076-16094. PubMed ID: 34606239 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary circulation-mediated heart targeting for the prevention of heart failure by inhalation of intrinsically bioactive nanoparticles. Liu C; Chen L; Ma Y; Hu K; Wu P; Pan L; Chen H; Li L; Hu H; Zhang J Theranostics; 2021; 11(17):8550-8569. PubMed ID: 34373758 [TBL] [Abstract][Full Text] [Related]
5. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases. Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099 [TBL] [Abstract][Full Text] [Related]
6. A reactive oxygen species-responsive antioxidant nanotherapy for the treatment of drug-induced tissue and organ injury. Li C; Hu Y; Nie Q; Chen S; Li G; Li L; Chen S; Tang B; Zhang J Biomater Sci; 2020 Dec; 8(24):7117-7131. PubMed ID: 33211787 [TBL] [Abstract][Full Text] [Related]
7. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease. Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680 [TBL] [Abstract][Full Text] [Related]
8. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis. Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000 [TBL] [Abstract][Full Text] [Related]
9. An auto-photoacoustic melanin-based drug delivery nano-platform for self-monitoring of acute kidney injury therapy via a triple-collaborative strategy. Zhao X; Sun J; Dong J; Guo C; Cai W; Han J; Shen H; Lv S; Zhang R Acta Biomater; 2022 Jul; 147():327-341. PubMed ID: 35643195 [TBL] [Abstract][Full Text] [Related]
10. Design of a new self-assembling antioxidant nanomedicine to ameliorate oxidative stress in zebrafish embryos. Shashni B; Tamaoki J; Kobayashi M; Nagasaki Y Acta Biomater; 2023 Mar; 159():367-381. PubMed ID: 36640953 [TBL] [Abstract][Full Text] [Related]
11. Polyphenol-assisted facile assembly of bioactive nanoparticles for targeted therapy of heart diseases. Qi Y; Li J; Nie Q; Gao M; Yang Q; Li Z; Li Q; Han S; Ding J; Li Y; Zhang J Biomaterials; 2021 Aug; 275():120952. PubMed ID: 34147720 [TBL] [Abstract][Full Text] [Related]
12. Synthetic ditempolphosphatidylcholine liposome-like nanoparticles for anti-oxidative therapy of atherosclerosis. Wang C; Zhao R; Wang Z; Xu T; Huang P RSC Adv; 2023 May; 13(24):16211-16221. PubMed ID: 37266511 [TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-Derived Intrinsically Bioactive Nanoparticles for Treatment of Acute and Chronic Inflammatory Diseases. Guo J; Li D; Tao H; Li G; Liu R; Dou Y; Jin T; Li L; Huang J; Hu H; Zhang J Adv Mater; 2019 Nov; 31(46):e1904607. PubMed ID: 31583783 [TBL] [Abstract][Full Text] [Related]
14. Novel gold-platinum nanoparticles serve as broad-spectrum antioxidants for attenuating ischemia reperfusion injury of the kidney. Feng S; Qu Y; Chu B; Chen X; Yang Z; Li P; Wang P; He Q; He Y; Lin T; Huang Z; Qian Z Kidney Int; 2022 Nov; 102(5):1057-1072. PubMed ID: 35870640 [TBL] [Abstract][Full Text] [Related]
15. A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease. Li S; Xie A; Li H; Zou X; Zhang Q J Control Release; 2019 Dec; 316():66-78. PubMed ID: 31682913 [TBL] [Abstract][Full Text] [Related]
16. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507 [TBL] [Abstract][Full Text] [Related]
17. An antioxidant nanodrug protects against hepatic ischemia-reperfusion injury by attenuating oxidative stress and inflammation. Zhang S; Cao Y; Xu B; Zhang H; Zhang S; Sun J; Tang Y; Wang Y J Mater Chem B; 2022 Sep; 10(37):7563-7569. PubMed ID: 35389415 [TBL] [Abstract][Full Text] [Related]
18. Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases. Babizhayev MA; Yegorov YE Am J Ther; 2016; 23(1):e98-117. PubMed ID: 21048433 [TBL] [Abstract][Full Text] [Related]
19. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin. Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the protective effects of berberine and berberine nanoparticle on insulin secretion and oxidative stress induced by carbon nanotubes in isolated mice islets of langerhans: an in vitro study. Golfakhrabadi F; Niknejad MR; Kalantari H; Dehghani MA; Shakiba Maram N; Ahangarpour A Environ Sci Pollut Res Int; 2023 Feb; 30(8):21781-21796. PubMed ID: 36279052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]